Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rapid Micro Biosystems Reports Preliminary Q4 FY23 Revenue Of $6.2M-$6.4M, Up 45% Y/Y Versus Consensus Of $6.25M

Author: Benzinga Newsdesk | January 10, 2024 08:24am

Posted In: RPID

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist